Literature DB >> 9702380

A review of the amyloidoses that infiltrate the heart.

R E McCarthy1, E K Kasper.   

Abstract

Primary amyloidosis, systemic senile amyloidosis, isolated atrial amyloidosis, and transthyretin isoleucine 122 amyloidosis frequently involve the heart. Amyloid fibrils infiltrate the myocardium, impairing ventricular contraction and relaxation. The clinical manifestations of cardiac infiltration in these disorders are protean, though congestive heart failure and arrhythmias are most common. Treatment of cardiac amyloidosis is directed at the underlying cause and at relief of symptoms. Heart transplantation is not a viable treatment option for patients with primary amyloidosis; its role in the other amyloidoses has not been established. The prognosis of patients with cardiac amyloidosis varies and is largely determined by the underlying disorder responsible for amyloid infiltration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9702380      PMCID: PMC6655639          DOI: 10.1002/clc.4960210804

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  12 in total

1.  The value of conventional echocardiographic and tissue doppler imaging in the diagnosis of cardiac amyloidosis.

Authors:  Li Zhang; Mingxing Xie; Xinfang Wang; Yali Yang; Junhong Huang; Ming Cheng; Feixiang Xiang; Qing Lü
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24

2.  Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain Amyloidosis.

Authors:  Paolo Milani; Angela Dispenzieri; Christopher G Scott; Morie A Gertz; Stefano Perlini; Roberta Mussinelli; Martha Q Lacy; Francis K Buadi; Shaji Kumar; Mathew S Maurer; Giampaolo Merlini; Suzanne R Hayman; Nelson Leung; David Dingli; Kyle W Klarich; John A Lust; Yi Lin; Prashant Kapoor; Ronald S Go; Patricia A Pellikka; Yi L Hwa; Stephen R Zeldenrust; Robert A Kyle; S Vincent Rajkumar; Martha Grogan
Journal:  Circ Cardiovasc Imaging       Date:  2018-05       Impact factor: 7.792

3.  A case of a senile systemic amyloidosis patient presenting with angina pectoris and dilated cardiomyopathy.

Authors:  Gu Hyun Kang; Dong Ryeol Ryu; Pil Sang Song; Young Bin Song; Joo-Yong Hahn; Seung-Hyuck Choi; Hyeon-Cheol Gwon
Journal:  Korean Circ J       Date:  2011-04-30       Impact factor: 3.243

Review 4.  Natural history and therapy of AL cardiac amyloidosis.

Authors:  Martha Grogan; Angela Dispenzieri
Journal:  Heart Fail Rev       Date:  2015-03       Impact factor: 4.214

5.  Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis.

Authors:  Nora S Green; Ted R Foss; Jeffery W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-29       Impact factor: 11.205

Review 6.  Amyloid in the cardiovascular system: a review.

Authors:  I Kholová; H W M Niessen
Journal:  J Clin Pathol       Date:  2005-02       Impact factor: 3.411

7.  Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis.

Authors:  Atsushi Sanbe; Hanna Osinska; Jeffrey E Saffitz; Charles G Glabe; Rakez Kayed; Alina Maloyan; Jeffrey Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-25       Impact factor: 11.205

8.  Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure.

Authors:  J Scott Pattison; Atsushi Sanbe; Alina Maloyan; Hanna Osinska; Raisa Klevitsky; Jeffrey Robbins
Journal:  Circulation       Date:  2008-05-19       Impact factor: 29.690

9.  Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.

Authors:  Andreia Biolo; Sujata Ramamurthy; Lawreen H Connors; Carl J O'Hara; Hans K Meier-Ewert; Pamela T Soo Hoo; Douglas B Sawyer; David C Seldin; David S Seldin; Flora Sam
Journal:  Circ Heart Fail       Date:  2008-10-14       Impact factor: 8.790

10.  Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors.

Authors:  Teresa Mairal; Joan Nieto; Marta Pinto; Maria Rosário Almeida; Luis Gales; Alfredo Ballesteros; José Barluenga; Juan J Pérez; Jesús T Vázquez; Nuria B Centeno; Maria Joao Saraiva; Ana M Damas; Antoni Planas; Gemma Arsequell; Gregorio Valencia
Journal:  PLoS One       Date:  2009-01-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.